title: Severe hypoalbuminaemia in a systemic lupus erythematosus-like patient.
abstract: Diffuse oedema due to hypoalbuminaemia is a common manifestation in patients affected with systemic lupus erythematosus. Hypoalbuminaemia is usually secondary to an ongoing glomerulonephritis leading to proteinuria or, more rarely, to decreased protein synthesis or deficient protein intake. Here, we report the case of a 6-year-old girl with a previous history of Evans' syndrome and mesangial glomerulonephritis who subsequently developed severe anasarca without apparent proteinuria. Faecal oal-antitrypsin showed a persistent severe intestinal protein loss (ranging from 1500 to 6.500 yl/g humid faeces, normal value < 200), consistent with the diagnosis of protein-losing enteropathy. An echographic examination of the abdomen revealed a diffuse thickening of the intestinal wall, particularly at the level of the small bowel, with an almost exclusive involvement of the submucosal layer. Colonoscopy revealed the presence of diffuse purpuric lesions at the level of the submucosa. Aggressive immunosuppressive treatment completely resolved the clinical picture.
  
  
  CONCLUSIONS
  protein-losing enteropathy is an uncommon cause of hypoalbuminaemia during the course of systemic lupus erythrematosus. It may be considered as a clinical syndrome related to many pathological conditions leading to an excessive intestinal protein loss. Some conditions are related with an altered mucosal permeability, others with primary or secondary intestinal lymphangiectasia. A review of the possible causes of systemic lupus erythrematosus-associated protein-losing enteropathy reported in the paediatric literature is given.
authors.affiliation: 2nd Division of Paediatrics, G. Gaslini Institute for Children, Genoa, Italy
authors.forename: Marco
authors.initials: M
authors.lastname: Gattorno
authors.forename: Antonella
authors.initials: A
authors.lastname: Buoncompagni
authors.forename: Arrigo
authors.initials: A
authors.lastname: Barabino
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Barbano
authors.forename: Anna
authors.initials: A
authors.lastname: Loy
authors.forename: Paolo
authors.initials: P
authors.lastname: Tomà
authors.forename: Paolo
authors.initials: P
authors.lastname: Picco
authors.forename: Alberto Maria
authors.initials: AM
authors.lastname: Marmont
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000418:Albumins / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis*; D011504:Protein-Losing Enteropathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000418:Albumins